Eric Rickman (41 results)

Paperback. Condition: Good. COPYRIGHT 1977. MAYBE JUST A READING COPY. 192 PAGE TEXT HAS LIGHT WEAR. CARS. 8.25'' X 11''. WE USE BUBBLE MAILERS.

Condition: Fair. 1952. 2nd impression. 260 pages. No dust jacket. Orange cloth with black lettering. Contains black and white photographic plates. Binding remains firm. Pages & plates are moderately tanned. Boards are slightly warped. Boards are slightly bowed. Boards have moderate edge-wear with bumping to corners and noticeable rubbing to surfaces.

Condition: Good. 2nd impression. DJ may have small chips and tears. Book will have been read but remains clean. Cover may have light wear or slight soiling. Pages may be slightly tanned. May contain inscriptions but text pages will be free from markings.

Hardcover. Condition: Very Good. No Jacket. First Edition. This is a Very Good Copy of this book in Publisher's green cloth with gilt title lettering to spine.No Dust-Jacket.There is some slight foxing to pre-lims and outer margins,otherwise a Very Good copy.Complete with 16 wonderful b&w plates.This copy is without any previous ownewrship inscriptions but does have a couple of Catholic Monastery stamps to the endpapers.The book has a firm binding with no hinge weakness.8vo 283pp First Edition 2nd Impression.

Hardcover. Condition: Very Good+. No Jacket. First Edition. This is a Very Good+ Copy of this Book in Publisher's brown cloth with black title lettering to spine.No Dust-Jacket.This copy has no previous inscriptions present.Well illustrated with over 20 b&w plates,8vo 260pp First Edition.

Condition: Fair. 1937. First Published. 283 pages. No dust jacket. Signed by the author. Green cloth with gilt lettering. Flatsigned by author to half title page. Black and white photographic plates. Light tanning to pages. More prominent to text block edges, pastedowns and free endpapers. Moderate cracking to gutters causing some looseness to binding but pages remain attached. Slight foxing to rear most pages. Boards have minor corner bumping and edgewear with mild scuffing overall. Spine has minor tanning with soft crushing to ends. Lettering remains bright and clear. Book has a slight forward lean.

1st Edition. Hb original green cloth binding ix,283pp frontisplate and illustrations Ink inscription to fep, dampstaining to boards (not affecting inside of Book) o/w A Vg copy.

Condition: Fair. 1951. 260 pages. No dust jacket. Green cloth with gilt lettering. Pages are moderately tanned at the edges, with notable foxing. Binding has remained firm. Inscription to front endpaper. Boards have slight shelf wear with bumping to corners. Spine ends are a little crushed with light tanning. Prominent forward lean to text block.

Hardcover. Condition: Good. No Jacket. Some wear to covers and spine, mainly edges and corners, corners a little bumped, top and bottom of spine bumped and worn, spine grubby, internally in good condition, pages crisp and clear.

hardcover. Condition: Good. Hardback. Dust jacket is torn and a lot of wear and tear (please see photos). Photograph available on request.

1937 publication with B&W illustrations; tightly bound in green cloth with gilt lettering to spine; corners slightly bumped, especially bottom front; scattered foxing to page fore-edges; otherwise, a good, tidy copy. Used - Good. Good hardback (no dust jacket).

Condition: Very Good. 1937. Hardback. Fine in fine cloth covers, lacking dust wrapper. Covers showing light age and shelf wear. Lightly toned, a little foxing on edges, text is crisp and clear and remains a fine copy. . . . .

Condition: Very Good. 1937. Hardback. Fine in fine cloth covers, lacking dust wrapper. Covers showing light age and shelf wear. Lightly toned, a little foxing on edges, text is crisp and clear and remains a fine copy. . . . . Books ship from the US and Ireland.

Hard back binding in publisher's original camel brown cloth covers, gilt title and author lettering to the spine. 8vo. 8½'' x 5½''. Contains 260 printed pages of text with monochrome photographs throughout. Very Good condition book in Good condition dust wrapper with two small pieces of paper missing to the top front cover and spine edges, not price clipped 21s. Dust wrapper supplied in archive acetate film protection, it does not adhere to the book or to the dust wrapper. Member of the P.B.F.A. SPORT [Horse Racing].

George Routledge & Sons, London 1937. ix, 283 pp. Publisher's cloth. Good condition.

hardcover. Condition: Good. Our good condition books are generally good for reading but not for gifting or collecting. They could have imperfections such as creasing, fanning, inscriptions, margin notes, yellowing, staining on edge or cover or pages, bumps, scuffs, etc etc (sometimes multiple of these). It's a wide category that encompasses anything that isn't almost-new down to anything that is slightly better than poor. We would NOT recommend gifting Good books - these should be considered reading copies. Our books are dispatched from a Yorkshire former cotton mill. We list via barcode/ISBN so please note that the images are stock images and may not be the exact copy you receive, furthermore the details about edition and year might not be accurate as many publishers reuse the same ISBN for multiple editions and as we simply scan a barcode or enter an ISBN we do not check the validity of the edition data when listing. If you're looking for an exact edition please don't order (at least not without checking with us first, although we don't always have time to check). We aim to dispatch prompty, the service used will depend on order value and book size. We can ship to most countries, see our shipping policies. Payment is via Abe only.

Hardcover. Condition: Very Good. 1st Edition. Octavo. ix, 283pp. Publisher's green cloth, gilt titles to spine. Some minor rubbing to extremities, very minor scratch to rear board. Illustrated. Light spotting to page ends. Otherwise a Very Good copy. Additional postage may be required for overseas orders.

8vo,pp.x + 260,index,illustrations.Original slightly faded green cloth hardcover, Signed by the Author.

First edition, second impression hard back binding in publisher's original green cloth covers, gilt title and author lettering to the spine. 8vo. 9'' x 6''. Contains 283 printed pages of text with monochrome photographic plates throughout. Spine ends turned-in with shallow rubs, pencil name to the front free end paper and in near Very Good condition, no dust wrapper. Member of the P.B.F.A. SPORT [Horse Racing].

Original Cloth. Condition: Near Very Good. No Jacket. First Edition. Light foxing to a few leaves, especially at the beginning. Signed by the author on the half-title. Signed by Author(s).

An explanation of horseracing. 8vo. 283pp. Cloth-covered boards. Good condition.

Condition: New. In.

Condition: New. In.

Gebunden. Condition: New.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. Most blinding [CG1]diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.Significant advances in these areas of retinal degenerations have been made since the last RD Symposium, RD2021. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2023 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that withsuccessful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that withsuccessful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

Taschenbuch. Condition: Neu. Neuware -This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the ¿best¿ and ¿most important¿ meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that withsuccessful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 612 pp. Englisch.

Buch. Condition: Neu. Neuware -This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the ¿best¿ and ¿most important¿ meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that withsuccessful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 612 pp. Englisch.

Hardcover. Condition: Brand New. 538 pages. 10.00x7.00x10.00 inches. In Stock.